Labeler · US market

Harbin Jixianglong Biotech Co., Ltd.

Harbin Jixianglong Biotech Co., Ltd. is a US drug labeler with US FDA registrations covering 2 drug concepts (2 currently active) across 14 packages.

ACTIVE — US

openFDA · updated weekly

Labeler codes84385

Active drugs2

Registrations2 active / 2

Packages14

Sole supplier of0 drugs

Portfolio2 drugs · US

Every drug concept this labeler has US registrations for, by package count.

Drug	Type	NDCs	Packages	Status
Tirzepatide powder	other	1	8	SUPPLYING
Retatrutide powder	other	1	6	SUPPLYING

At a glance

TypeLabeler
Labeler codes84385
Filing names1
Drugs (active)2
Drugs (all time)2
US registrations2
Packages14

Recent events

Shortages, recalls, and registration changes across all filing names.

Feb 13, 2026
RECALLRecall (Class II): Semaglutide, For Rx compounding use only, packaged in a) 1g, NDC 84385-106-01; b) 5g, NDC 84385-106-02; c) 10g, NDC 84…
Feb 13, 2026
RECALLRecall (Class II): Semaglutide, For Rx compounding use only, packaged in a) 1g, NDC 84385-106-01; b) 5g, NDC 84385-106-02; c) 10g, NDC 843…

Watch this company

Alerts for recalls, exits, and new registrations.

Facility locations, FDA inspections, and parent-company mapping are on the roadmap. Name variants reported to FDA under different spellings are merged into this profile; figures cover the entity across all its filing names.